Skip to main content

Table 1 Characteristics of patients

From: TAM receptor ligands in lupus: Protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus

 

Lupus matched

(n= 45)

Normal control

(n= 45)

Lupus unmatched

(n= 62)

Age (years)

40.47 ± 15.5

41.38 ± 15.9

37.27 ± 13.02

Sex (F:M)

34:11

34:11

51:11

Ethnicity

   

Caucasian

41

41

54

African

2

2

2

Asian

1

1

3

American Indian

1

1

3

ACR total

5.51 ± 1.69

 

5.53 ± 1.72

Anti-dsDNA Ab (%)

33.3

 

22.6

Anti-Sm Ab (%)

28.9

 

12.5

Anti-Ro (SSA) Ab (%)

42.2

 

35.5

Anti-La (SSB) Ab (%)

8.9

 

22.6

Anticardiolipin Ab (%)

48.8

 

35.7

Lupus anticoagulant (%)

15.6

 

11.7

Anti-B2 glycoprotein Ab (%)

11.1

 

14.5

APS (%)

37.8

 

14.8

Decreased C3 (%)

8.9

 

4.8

Decreased C4 (%)

42.2

 

30.7

SLEDAI

6.02 ± 4.3

 

4.75 ± 4.08

BILAG

6.93 ± 5.34

 

5.59 ± 3.73

  1. Ab, antibody; ACR total, the number of American College of Rheumatology 1982 revised criteria for classification of systemic lupus erythematosus; APS, antiphospholipid syndrome; BILAG, British Isles Lupus Assessment Group; F, female; M, male; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us